INDUSTRY NOTES: OIG To Oncologists--Tighten Your Belts

Why This Topic Matters

The piece flags Medicare policy and compliance issues that can affect reimbursement, denial management, and practice operations. It also highlights ongoing federal attention to drug payment adequacy, radiology claims processing, and billing practices that may be relevant to oncology and other physician practices.

Article Sections

1. Cancer drug payment oversight

   Summarizes an OIG review of oncology practices and Medicare payment adequacy for cancer drugs. Discusses the general reporting findings and CMS response at a high level.

2. Radiology denials on admission and discharge dates

   Explains a CMS edit affecting radiology technical component claims and notes the timing of the change described in the article. Includes general guidance about reviewing affected denials and appealing when appropriate.

3. In Other News...

   Covers a set of short healthcare industry items on electronic medical records, breast cancer prevention, healthcare costs, and billing compliance. These are brief contextual updates rather than detailed coding guidance.